Clovis Oncology, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Clovis Oncology, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $4.96 million as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2022-02-24
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $4.96M.
- 2021-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.03M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.03M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $2.94M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2021-12-31 | $4.96M 10-K · filed 2022-02-24 |
| 2021-03-31 | $5.03M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $5.03M 10-K · filed 2021-02-25 |
| 2019-12-31 | $2.94M 10-K · filed 2020-02-26 |
| 2019-09-30 | $2.95M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.35M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $2.34M 10-Q · filed 2019-05-07 |